Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background: Cancer of unknown primary (CUP) remains a diagnostic and therapeutic challenge, particularly when involving rare histological and molecular subtypes. Mucinous adenocarcinoma (MAC) with neuroendocrine differentiation is exceptionally rare, and its molecular characteristics are poorly understood. Materials and methods: We report a case of CUP initially presenting with multiple liver and bone metastases.
Comment on “Circulating fatty acids and risk of severe non-alcoholic fatty liver disease in the UK biobank: a prospective cohort of 116 223 individuals” by P. Zhuang, Y. Ao, X. Liu, H. Ye, H. Li, X. Wan, Y. Zhang and J. Jiao, Food & Function, 2024, 15, 10527† The first page of this article is displayed as the abstract. This article is Open Access This article has not yet been cited.
Introduction Hepatocellular carcinoma (HCC) is an aggressive malignant tumor that affects more than 600,000 people worldwide (1). Because of the high incidence of hepatitis virus infection, China has been considered as a “large country for liver cancer” (2). With advancing methods, such as new targeting concepts and immune therapies, clinicians not only significantly prolong the survival of patients but also improve their quality of life.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.